Dominion Energy Inc operates a large regulated electric and gas utility network in the U.S., with its earnings tied to capital spending, regulatory returns, and power demand. The company focuses on capital investments for grid modernization and integrating renewable energy, balancing reliability and affordability while navigating the energy transition. Its stable, regulated utility model provides predictable cash flows, making it relevant for income-oriented investors, while operational reliability and a disciplined financing strategy are key to its sustained success.

American Express has expanded its partnership with Apple, allowing cardholders to redeem rewards points at checkout via Apple Pay online or in-app. This move is part of Amex's strategy to integrate more businesses into its loyalty program, following similar initiatives with Fanatics. The collaboration builds on a long-standing relationship between the two companies, facing competition in the payments landscape.

US Bancorp retirees have dropped their Eighth Circuit appeal regarding the bank's pension calculations for early retirees. The lawsuit alleged that US Bancorp used outdated life expectancy data, leading to shortchanged monthly benefits for those who chose non-traditional pension formats. The retirees had sought review of a previous decision that favored the bank, which stated that federal benefits law does not require implicit "reasonableness" for actuarial assumptions.

This article from Investing.com reports on a Form 4 filing for Public Storage (PSA) on July 2nd. It provides the stock's current performance, showing an increase of 0.86%, and briefly lists various market data, including indices, commodities, and individual stock performances.

HCA Healthcare (HCA) saw a 3.6% increase in its stock price, likely driven by positive analyst reports regarding improving physician staffing trends in the second quarter. This rebound follows earlier pressure on the stock due to reduced 2026 earnings guidance. The article also details recent insider trading activity, primarily sales, and significant institutional investor movements, alongside analyst ratings and price targets for HCA.

The U.S. Federal Aviation Administration (FAA) has issued new airworthiness directives for Boeing aircraft due to Canada's enhanced 5G Lower C-band environment. These directives impose operating restrictions on planes lacking radio altimeters proven to withstand the updated 5G interference, which became effective July 1 after Canada removed airport exclusion zones. The FAA's action follows a report from Transport Canada about a more severe 5G interference environment and Boeing's analysis indicating certain configurations won't tolerate it, leading to model-specific directives for various Boeing aircraft.

This article reports on a Form 144 filing for LAM RESEARCH CORP (LRCX) on July 2nd. It is a brief announcement from Investing.com, typical of their financial news alerts. The article also includes various market data and related news headlines.

Ohio Representative David Taylor recently purchased between $2,002 and $30,000 worth of Chevron (NYSE: CVX) stock on June 15, 2026, as disclosed in a July 1, 2026 report. This adds to his 200 stock trades totaling over $312,000 in the past three years, which included transactions in UnitedHealth Group and Eli Lilly. The article highlights the importance of congressional transaction disclosures under the STOCK Act as a factor, but not the sole reason, for investment decisions.

This article announces the filing of Form 144 for Schwab Charles Corp on July 2nd, as reported by Investing.com. It is a brief, standard financial news update, likely indicating an insider's intent to sell restricted stock. The piece also includes various financial market data and related news headlines.

Pfizer's updated Comirnaty COVID-19 vaccine for 2024-2025 targets Omicron XBB-lineage variants and is a key component of the U.S. fall booster campaign. The article details its distribution, pricing shifts from government to commercial channels, and highlights its role as a significant, though no longer dominant, product in Pfizer's diversified portfolio. It also covers practical aspects from pharmacy operations to investor considerations.